BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38040059)

  • 21. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
    Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
    Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.
    Min CH; Paganetti H; Winey BA; Adams J; MacDonald SM; Tarbell NJ; Yock TI
    Radiat Oncol; 2014 Nov; 9():220. PubMed ID: 25403752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.
    Eaton BR; Esiashvili N; Kim S; Patterson B; Weyman EA; Thornton LT; Mazewski C; MacDonald TJ; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
    Neuro Oncol; 2016 Jun; 18(6):881-7. PubMed ID: 26688075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.
    Giantsoudi D; Sethi RV; Yeap BY; Eaton BR; Ebb DH; Caruso PA; Rapalino O; Chen YE; Adams JA; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):287-296. PubMed ID: 26691786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
    Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function.
    Merchant TE; Hua CH; Shukla H; Ying X; Nill S; Oelfke U
    Pediatr Blood Cancer; 2008 Jul; 51(1):110-7. PubMed ID: 18306274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors.
    Pulsifer MB; Duncanson H; Grieco J; Evans C; Tseretopoulos ID; MacDonald S; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):391-398. PubMed ID: 30108004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.
    Hsieh RC; Lee CH; Huang HC; Wu SW; Chou CY; Hung SP; Lee CW; Krishnan S; Venkatesulu BP; Lee JC; Chou YC; Chan KM; Lin PT; Lee WC; Lin CC; Lin SY; Hong JH
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):712-724. PubMed ID: 37778426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes.
    Grill J; Renaux VK; Bulteau C; Viguier D; Levy-Piebois C; Sainte-Rose C; Dellatolas G; Raquin MA; Jambaqué I; Kalifa C
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):137-45. PubMed ID: 10477017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the effects of irradiation with protons or photons on neonatal mouse brain: Apoptosis, oncogenesis and hippocampal alterations.
    Giovannini D; Antonelli F; Casciati A; De Angelis C; Denise Astorino M; Bazzano G; Fratini E; Ampollini A; Vadrucci M; Cisbani E; Nenzi P; Picardi L; Saran A; Marino C; Mancuso M; Ronsivalle C; Pazzaglia S
    Radiother Oncol; 2024 Jun; 195():110267. PubMed ID: 38614282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.
    Zhang R; Howell RM; Giebeler A; Taddei PJ; Mahajan A; Newhauser WD
    Phys Med Biol; 2013 Feb; 58(4):807-23. PubMed ID: 23322160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of medulloblastoma.
    Jones B; Wilson P; Nagano A; Fenwick J; McKenna G
    Br J Radiol; 2012 Oct; 85(1018):e912-8. PubMed ID: 22553304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
    Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
    Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
    Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.
    Brown AP; Barney CL; Grosshans DR; McAleer MF; de Groot JF; Puduvalli VK; Tucker SL; Crawford CN; Khan M; Khatua S; Gilbert MR; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):277-84. PubMed ID: 23433794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma.
    Blomstrand M; Brodin NP; Munck Af Rosenschöld P; Vogelius IR; Sánchez Merino G; Kiil-Berthlesen A; Blomgren K; Lannering B; Bentzen SM; Björk-Eriksson T
    Neuro Oncol; 2012 Jul; 14(7):882-9. PubMed ID: 22611031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
    Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children.
    Yuh GE; Loredo LN; Yonemoto LT; Bush DA; Shahnazi K; Preston W; Slater JM; Slater JD
    Cancer J; 2004; 10(6):386-90. PubMed ID: 15701271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy.
    Moeller BJ; Chintagumpala M; Philip JJ; Grosshans DR; McAleer MF; Woo SY; Gidley PW; Vats TS; Mahajan A
    Radiat Oncol; 2011 Jun; 6():58. PubMed ID: 21635776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.